Skip to main content

Milestone 9.D

Incorporate imaging and/or fluid biomarkers into Phase II (proof of concept) drug trials to provide proof of mechanism and/or evidence of target engagement as trials for 3-6 existing and 3-6 novel therapeutic targets are initiated.


Success Criteria

Enrich 3-6 Phase II (proof of concept) drug trials with imaging and/or fluid biomarkers for proof of target engagement and proof of clinical mechanisms.


Research Implementation Area
Biomarkers
Timeline
2017–2023
Status
Achieved

Accomplishments/Implementation Activities

Funding Initiatives

Research Programs and Resources

Relevant Recommendations